258 related articles for article (PubMed ID: 17971074)
1. The contribution of cerebral vascular semicarbazide-sensitive amine oxidase to cerebral amyloid angiopathy in Alzheimer's disease.
Jiang ZJ; Richardson JS; Yu PH
Neuropathol Appl Neurobiol; 2008 Apr; 34(2):194-204. PubMed ID: 17971074
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy.
Miners JS; Ashby E; Van Helmond Z; Chalmers KA; Palmer LE; Love S; Kehoe PG
Neuropathol Appl Neurobiol; 2008 Apr; 34(2):181-93. PubMed ID: 17973905
[TBL] [Abstract][Full Text] [Related]
3. Cross-talk between Aβ and endothelial SSAO/VAP-1 accelerates vascular damage and Aβ aggregation related to CAA-AD.
Solé M; Miñano-Molina AJ; Unzeta M
Neurobiol Aging; 2015 Feb; 36(2):762-75. PubMed ID: 25457560
[TBL] [Abstract][Full Text] [Related]
4. Involvement of cerebrovascular semicarbazide-sensitive amine oxidase in the pathogenesis of Alzheimer's disease and vascular dementia.
Yu PH
Med Hypotheses; 2001 Aug; 57(2):175-9. PubMed ID: 11461168
[TBL] [Abstract][Full Text] [Related]
5. Human plasma semicarbazide sensitive amine oxidase (SSAO), beta-amyloid protein and aging.
del Mar Hernandez M; Esteban M; Szabo P; Boada M; Unzeta M
Neurosci Lett; 2005 Aug 12-19; 384(1-2):183-7. PubMed ID: 15894424
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease.
van Helmond ZK; Miners JS; Bednall E; Chalmers KA; Zhang Y; Wilcock GK; Love S; Kehoe PG
Neuropathol Appl Neurobiol; 2007 Jun; 33(3):317-27. PubMed ID: 17493012
[TBL] [Abstract][Full Text] [Related]
7. Relationships in Alzheimer's disease between the extent of Abeta deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen.
Tian J; Shi J; Smallman R; Iwatsubo T; Mann DM
Neuropathol Appl Neurobiol; 2006 Jun; 32(3):332-40. PubMed ID: 16640651
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.
Attems J; Jellinger KA; Lintner F
Acta Neuropathol; 2005 Sep; 110(3):222-31. PubMed ID: 16133541
[TBL] [Abstract][Full Text] [Related]
9. Semicarbazide-sensitive amine oxidase (SSAO) and its possible contribution to vascular damage in Alzheimer's disease.
Unzeta M; Solé M; Boada M; Hernández M
J Neural Transm (Vienna); 2007; 114(6):857-62. PubMed ID: 17393059
[TBL] [Abstract][Full Text] [Related]
10. Alpha7 nicotinic acetylcholine receptor expression by vascular smooth muscle cells facilitates the deposition of Abeta peptides and promotes cerebrovascular amyloid angiopathy.
Clifford PM; Siu G; Kosciuk M; Levin EC; Venkataraman V; D'Andrea MR; Nagele RG
Brain Res; 2008 Oct; 1234():158-71. PubMed ID: 18708033
[TBL] [Abstract][Full Text] [Related]
11. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA
Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056
[TBL] [Abstract][Full Text] [Related]
12. Protein cross-linkage induced by formaldehyde derived from semicarbazide-sensitive amine oxidase-mediated deamination of methylamine.
Gubisne-Haberle D; Hill W; Kazachkov M; Richardson JS; Yu PH
J Pharmacol Exp Ther; 2004 Sep; 310(3):1125-32. PubMed ID: 15128865
[TBL] [Abstract][Full Text] [Related]
13. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study.
Attems J; Jellinger KA
Acta Neuropathol; 2004 Feb; 107(2):83-90. PubMed ID: 14655019
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of semicarbazide sensitive amine oxidase in the cerebral blood vessels in patients with Alzheimer's disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
Ferrer I; Lizcano JM; Hernández M; Unzeta M
Neurosci Lett; 2002 Mar; 321(1-2):21-4. PubMed ID: 11872247
[TBL] [Abstract][Full Text] [Related]
15. UV light-induced autofluorescence of full-length Abeta-protein deposits in the human brain.
Thal DR; Ghebremedhin E; Haass C; Schultz C
Clin Neuropathol; 2002; 21(1):35-40. PubMed ID: 11846043
[TBL] [Abstract][Full Text] [Related]
16. Cerebral amyloid angiopathy and dementia.
Tian J; Shi J; Mann DM
Panminerva Med; 2004 Dec; 46(4):253-64. PubMed ID: 15876981
[TBL] [Abstract][Full Text] [Related]
17. Oxidative damage of 14-3-3 zeta and gamma isoforms in Alzheimer's disease and cerebral amyloid angiopathy.
Santpere G; Puig B; Ferrer I
Neuroscience; 2007 Jun; 146(4):1640-51. PubMed ID: 17445990
[TBL] [Abstract][Full Text] [Related]
18. Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer's disease pathogenesis.
Castellani RJ; Smith MA; Perry G; Friedland RP
Neurobiol Aging; 2004; 25(5):599-602; discussion 603-4. PubMed ID: 15172735
[TBL] [Abstract][Full Text] [Related]
19. Cerebral amyloid angiopathy in the elderly: vessel walls changes and relationship with dementia.
Zekry D; Duyckaerts C; Belmin J; Geoffre C; Moulias R; Hauw JJ
Acta Neuropathol; 2003 Oct; 106(4):367-73. PubMed ID: 12898153
[TBL] [Abstract][Full Text] [Related]
20. Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype.
Tanskanen M; Lindsberg PJ; Tienari PJ; Polvikoski T; Sulkava R; Verkkoniemi A; Rastas S; Paetau A; Kiuru-Enari S
Neuropathol Appl Neurobiol; 2005 Dec; 31(6):589-99. PubMed ID: 16281907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
